✦ LIBER ✦

OP2 Nab-paclitaxel in the treatment of advanced pancreatic cancer refractory to gemcitabine – Final results of a phase 2 trial

✍ Scribed by G. de Lima Lopes; P. Hosein; C. Gomez; V. Pastorini; J. Macintyre; M. Easey; I. Reis; J. Merchan; P. Bejarano; C. Rocha-Lima

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3543 POSTER Phase I trial of capecitabin

✍ M. Michael; T. Price; T. Leong; V. Ganju; A. Strickland; M. Jefford; S. Ngan; A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Mature Results of a Phase II Trial of Ge

✍ Antoinette J. Wozniak; Kimberly Belzer; Lance K. Heilbrun; Omer Kucuk; Shirish G 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 125 KB

470 Final results of a phase II study of

✍ S. Glück; C. Lobo; G. Lopes; A. Castrellon; J. Hurley; I. Reis; S. Richman; O. S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Phase II trial of nab-paclitaxel in the

✍ David S. Alberts; John A. Blessing; Lisa M. Landrum; David P. Warshal; Lainie P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 209 KB

O-0004 * SPARC ANALYSIS IN THE PHASE III

✍ Hidalgo, M.; Plaza, C.; Illei, P.; Brachmann, C.; Heise, C.; Pierce, D.; Romano, 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 36 KB

A phase 2 clinical trial of sequential n

✍ Arlene O. Siefker-Radtke; Colin P. Dinney; Yu Shen; Dallas L. Williams; Ashish M 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB